First Ever Wireless Drug-Dispensing Chip Is Tested

Imagine a patient who has a chronic disease and has to go to a hospital every week to get an injection. If there was some way that a drug was automatically entered into his body every one week, that would make his life so much more easier. This is what a wireless drug-dispensing chip can accomplish. It can be wirelessly told to send a dose of drug to the patient’s body, whereas the chip itself is implanted in the human body.


Researchers have been carrying out tests related to this specific drug-dispensing chip. The initial results clearly affirm that neither the chip nor the mechanism or providing drugs through the drug has any side-effects on the patients. On the contrary, the body responds perfectly normally to wireless drug-dispensing.

In the initial test that was carried out, the researchers implanted the chips in eight women with osteoporosis. The chips were intact for a total of four months and during that time, each chip held about 20 daily doses for the patient.

So how are doses kept in the chip and what makes them go into the body? The dose is kept behind a thin coating of titanium and platinum. Then when an electrical charge is sent to the chip, that melts that thin film and as a result, the dose is released into the body. This electrical charge is usually sent wirelessly.

The results of the study have also reassured the researchers that using a chip or administering doses through a chip does not bear any side-effects on the body of the patients.

This is a remarkable step forward in that it can entirely revolutionize the drug-administering process in hospitals and be a source of immense relief for those with a chronic condition. It  can let patients get rid of the need to go to hospitals on a regular basis.

[ttjad]

Salman

Salman Latif is a software engineer with a specific interest in social media, big data and real-world solutions using the two.Other than that, he is a bit of a gypsy. He also writes in his own blog. You can find him on Google+ and Twitter .

Leave a Reply